Compare Abbott Laboratories (ABT) vs Nerdwallet Inc (NRDS) Price & Performance

Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.

The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.

NRDS trades at $9.50, up 0.32% today, with a bullish technical signal from moving averages but overbought short-term RSI readings. The company shows strong fundamental improvement, with revenue growing from $539M in 2022 to $837M in 2025 and net income turning positive to $48.7M. Recent quarters have consistently beaten EPS estimates, and analyst consensus is a Buy with a $12.75 target, implying 34% upside. Positive news highlights the company's pivot to higher-margin transactions and resilience amid search headwinds.

The outlook is positive given strong earnings beats, robust cash flow, and attractive valuation multiples like a P/E of 10.19. Key risks include reliance on search traffic, competitive pressures, and projected negative net cash flow in 2026. Institutional sentiment is bullish, but investors should monitor execution on growth initiatives and macroeconomic impacts on consumer finance behavior.